MRX Foundation

MRX Foundation Global Initiatives to Accelerate Humanity. Utilizing advanced technologies to increase the living standards of all Populations in all Countries.

10/05/2026

Our AI Fight Club™ synthetic environment enables large-scale AI testing in simulation, helping ensure our AI is ready for reality. The data gathered from testing and simulation during our first AI Fight Club event with our Skunk Works® team, Ansys Government Initiatives (AGI) and ATG is critical in developing AI solutions that enhance speed, accuracy and decision making for military operations.

01/11/2025

💉 Scientists just tested an mRNA vaccine that could fight any cancer!

This shot helps your immune system see and destroy cancer — no matter the type.

The future of treatment is here.

A team at the University of Florida has developed an experimental mRNA cancer vaccine that could teach the immune system to fight many types of tumors — not just one.

Instead of zeroing in on a single cancer marker, this vaccine trains the body to recognize and attack cancer broadly, much like it responds to a virus. In lab tests, when paired with existing immunotherapy drugs, the vaccine triggered a strong immune reaction that shrank stubborn tumors in mice — including cancers that had resisted treatment before.

What sets this approach apart is how it forces tumors to reveal themselves. The vaccine boosts type-I interferon signals and pushes tumor cells to display PD-L1, a flag that makes them easier for the immune system to target. It’s a new way of helping the body “see” cancer — and destroy it. While still in early testing, the results suggest a potential universal cancer vaccine, one that could someday complement or even replace chemotherapy, radiation, and surgery. The goal is simple yet revolutionary: teach the immune system to recognize cancer for what it is — and fight back.

📖 Source: Qdaisat, Sadeem, et al. “Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreading.” Nature Biomedical Engineering, July 18, 2025.

10/10/2025
08/10/2025

Congratulations to our members John Clarke, Michel H. Devoret, and John M. Martinis, winners of the 2025 Nobel Prize in Physics for their groundbreaking experiments revealing quantum tunneling in electrical circuits.

A fitting recognition during the International Year of Quantum 2025, their work helped bring quantum mechanics from the microscopic to the macroscopic world.

We’re proud to have published their winning research in Physical Review Letters — and all three papers are now free to read. In addition, all three laureates have been APS members for decades and Clarke and Martinis are APS Fellows.

Supported in part by the U.S. Department of Energy, the U.S. National Science Foundation, IBM, and the Commissariat à l'Energie Atomique in France, this achievement is a reminder that international collaboration and sustained investment are essential to scientific and technological innovation.

01/10/2025
29/08/2025
05/08/2025

From Mussolini to Trump, falsifying economic data has been used to maintain the illusion of competence, even when reality tells a very different story.
 
Just last week, Trump fired Dr. Erika McEntarfer, Commissioner of the Bureau of Labor Statistics, after a jobs report didn’t fit his narrative. This is part of a familiar authoritarian playbook: silencing truth tellers and manipulating data to hide the real impact of harmful policies.
 
Link in bio to read my latest essay on how “cook” economic numbers to maintain power — and why these tactics matter now more than ever.
 

27/07/2025

The Office of Research and Development produced the science underpinning regulations on everything from PFAS to pesticides to lead. For more than half a century, the Environmental Protection Agency’s Office of Research and Development, or ORD, has furnished the EPA with independent research on eve...

Adresse

Monaco

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque MRX Foundation publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Partager